WQ

Medapp SAFRA Medapp Stock Report

Last reporting period 31 Dec, 2023

Updated 22 Oct, 2024

Last price

Market cap $B

0

Micro

Exchange

XFRA - Deutsche Boerse AG

WQ1.F Stock Analysis

WQ

Uncovered

Medapp SA is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-21/100

Low score

Market cap $B

0

Dividend yield

Shares outstanding

250.13 B

MedApp SA engages in the provision of mobile marketing solutions in the field of medicine. The company is headquartered in Krakow, Woj. Malopolskie. The company went IPO on 2011-10-19. The firm provides a software application, named Carna Life, which is used in telemedicine sector. Carna Life serves as communication channel between doctors and patient. Carna Life is a telemedicine system that enables patients to upload test results and receive doctor's interpretation. The application operates in online (upload and download of data) and offline (review of data) mode. Carna Life provides statistics, graphic visualizations and tables with interpreted data. The firm is controlled by Moonrock Enterprise SA.

View Section: Eyestock Rating